Abstract
Myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal hematologic melignities, characteristic with failure of hematopoietic stem cell. The disease is connected with inneficient hematopoiesis and cytopenia and increased risk of acute myeloid leukemia